Related references
Note: Only part of the references are listed.Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro
Ke Lan et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia
Marco Herling et al.
BLOOD (2008)
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)
J. Duerig et al.
LEUKEMIA (2007)
Bortezomib induces apoptosis in T-cell prolymphocytic leukemia (T-PLL)
Fulya Ozpuyan et al.
LEUKEMIA & LYMPHOMA (2007)
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia:: graft-versus-tumor effect and long-term remission
H de Lavallade et al.
BONE MARROW TRANSPLANTATION (2006)
Molecular and cellular mechanisms of T Cell development
U Bommhardt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
T-cell prolymphocytic leukemia with der(11)t(1;11)(q2 1;q23) and ATM deficiency
M Yamaguchi et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
J Delgado et al.
LEUKEMIA & LYMPHOMA (2002)
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed
MJ Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
T-cell receptor γδ T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype
T Sugimoto et al.
ANNALS OF HEMATOLOGY (2001)
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
CE Dearden et al.
BLOOD (2001)
A complex pattern of recurrent chromosomal bosses and gains in T-cell prolymphocytic leukemia
J Soulier et al.
GENES CHROMOSOMES & CANCER (2001)
Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation
L Garderet et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
The protooncogene TCL1 is an Akt kinase coactivator
J Laine et al.
MOLECULAR CELL (2000)
Share Paper
